HIV integrase inhibitors

Details for Australian Patent Application No. 2005251820 (hide)

Owner Merck & Co., Inc.

Inventors Langford, H. Marie; Wai, John, S.; Williams, Pete, D.

Agent Spruson & Ferguson

Pub. Number AU-A-2005251820

PCT Pub. Number WO2005/120516

Priority 60/578,170 09.06.04 US

Filing date 3 June 2005

Wipo publication date 22 December 2005

International Classifications

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

Event Publications

30 November 2006 PCT application entered the National Phase

  PCT publication WO2005/120516 Priority application(s): WO2005/120516

6 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005251823-Latching means for a safety seat

2005251818-Vaccine compositions and methods